Tonix Pharma (TNXP)

Tonix Pharma (TNXP) Stock Price & Analysis


TNXP Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.29 - $7.74
Previous Close$0.58
Average Volume (3M)3.73M
Market Cap
Enterprise Value-$83.37M
Total Cash (Recent Filing)$120.23M
Total Debt (Recent Filing)$760.00K
Price to Earnings (P/E)-0.1
May 15, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-4.09
Shares Outstanding62,663,898
10 Day Avg. Volume1,049,816
30 Day Avg. Volume3,733,992
Standard Deviation0.39
Financial Highlights & Ratios
Price to Book (P/B)0.17
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-0.20
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-10.00T>
Enterprise Value/Ebitda0.75
Price Target Upside1026.13% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2



Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Tonix Pharma’s price range in the past 12 months?
Tonix Pharma lowest stock price was $0.29 and its highest was $7.74 in the past 12 months.
    What is Tonix Pharma’s market cap?
    Currently, no data Available
    When is Tonix Pharma’s upcoming earnings report date?
    Tonix Pharma’s upcoming earnings report date is May 15, 2023 which is in 49 days.
      How were Tonix Pharma’s earnings last quarter?
      Tonix Pharma released its earnings results on Mar 13, 2023. The company reported -$0.56 earnings per share for the quarter, beating the consensus estimate of -$0.86 by $0.3.
        Is Tonix Pharma overvalued?
        According to Wall Street analysts Tonix Pharma’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Tonix Pharma pay dividends?
          Tonix Pharma does not currently pay dividends.
          What is Tonix Pharma’s EPS estimate?
          Tonix Pharma’s EPS estimate is -$0.53.
            How many shares outstanding does Tonix Pharma have?
            Tonix Pharma has 62,539,497 shares outstanding.
              What happened to Tonix Pharma’s price movement after its last earnings report?
              Tonix Pharma reported an EPS of -$0.56 in its last earnings report, beating expectations of -$0.86. Following the earnings report the stock price went up 12.903%.
                Which hedge fund is a major shareholder of Tonix Pharma?
                Currently, no hedge funds are holding shares in TNXP


                Tonix Pharma Stock Smart Score

                The Tonix Pharma stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                Learn more about TipRanks Smart Score

                Company Description

                Tonix Pharma

                Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company. It focuses on discovering and developing small molecules and biologics to treat psychiatric, pain and addiction conditions, to improve biodefense through potential medical counter-measures, to treat transplant rejection and to treat gastric and pancreatic cancers. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and Tonmya. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in New York, NY.


                Top 5 ETFs holding TNXP

                Currently, no data available
                Please return soon. This page is being updated.
                Up to five ETFs with an Outperform Smart Score that hold TNXP. The ETFs are listed according to market value of TNXP within the ETF


                Forecast EPS vs Actual EPS

                Similar Stocks
                Price & Change
                Theralink Technologies
                Sio Gene Therapies
                Harpoon Therapeutics
                Jasper Therapeutics

                Popular Stocks

                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis